Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label KRAS. Show all posts
Showing posts with label KRAS. Show all posts
Saturday, May 26, 2012

[Biomarker for colorectal cancer] - Lynch Syndrome/MSI/KRAS/BRAF

›
[Biomarker for colorectal cancer] Abstract Discovery of usable molecular biomarkers is the step closer to a realization of personalize...

PLoS ONE: The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer (study of pts with both ovarian and breast cancers)

›
Blogger's Note: the other cancers (KRAS mutations) referred to beyond ovarian and breast cancers include references to lung and melano...
Saturday, March 31, 2012

(Apr 2012) Commentary: Link between endometriosis and ovarian-cancer subtypes : The Lancet Oncology

›
Link between endometriosis and ovarian-cancer subtypes : The Lancet Oncology "Previous large epidemiological studies have attempte...
Saturday, February 04, 2012

abstract: KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis (study of KRAS/BRAF mutations)

›
Summary The association between ovarian endometrioid adenocarcinoma and endometriosis is well established. However, not all endometrio...
Friday, June 03, 2011

Mutational analysis and clinical correlation of 185 consecutive metastatic colorectal patients: Similarities and differences between colon and rectal patients| 2011 ASCO Abstract

›
Conclusions: Rectal and colon patients have similar rates of KRAS and PIK3CA mutations. However, BRAF mutations are more common in co...
Tuesday, April 19, 2011

Markman: KRAS Mutations in Ovarian Cancer -- Maybe Not

›
Saturday, March 19, 2011

Medical News: SGO: Mutation Link to Ovarian Cancer Disputed - in Meeting Coverage, SGO from MedPage (KRAS mutation)

›
Saturday, August 14, 2010

Expert Opinion on Medical Diagnostics - KRAS mutations - Summary

›
What the reader will gain: KRAS mutations in mCRC and NSCLC primary tumors predict resistance to EGFR-targeted therapy. In pancreatic cance...
Wednesday, July 21, 2010

A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk (full access)

›
Tuesday, June 15, 2010

A KRAS-variant as a biomarker of ovarian cancer risk

›
Note: KRAS has been studied in colorectal cancer impacting on treatment program/no indication if ovarian cancer/Lynch Syndrome patients were...
Wednesday, May 12, 2010

Review Unmasking the complexities of mucinous ovarian carcinoma

›
Note: mucinous/KRAS is also prevalant in colorectal cancers Conclusions Primary mucinous ovarian cancer should be considered separate fr...